Stocktoria

LeonaBio, Inc. LONA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-09-18

LeonaBio, Inc. statistics & valuation

Market cap$88.3M
P / B3.2×
Return on capital-229%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-7.30% -17.10% -40.70% -90.40% -216.20% -380.00% 2019202020212022202320242025
Shares outstanding
3.6M 32.5M 37.4M 37.9M 38.2M 3.9M 9.3M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-235.80% -7.10% -16.50% -37.00% -73.40% -164.90% -114.60% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$1.49 -$2.53 -$3.09 -$25.19 -$24.70 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-114.6%-164.9%-73.4%-37.0%-16.5%-7.1%-235.8%
Return on equity-380.0%-216.2%-90.4%-40.7%-17.1%-7.3%26.2%
Current ratio1.884.185.379.6828.0743.661.70

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.